A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.
The current in vivo models for the utility and discovery of new potential anti-leishmanial drugs targeting Cutaneous Leishmaniasis (CL) differ vastly in their immunological responses to the disease and clinical presentation of symptoms. Animal models that show similarities to the human form of CL af...
Main Authors: | Emily Rose Mears, Farrokh Modabber, Robert Don, George E Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4559374?pdf=render |
Similar Items
-
Investigation into in vitro anti-leishmanial combinations of calcium channel blockers and current anti-leishmanial drugs
by: Juliana Quero Reimão, et al.
Published: (2011-12-01) -
Colonization and Biology of Phlebotomus papatasi, the Main Vector of Cutaneous Leishmaniasis due to Leshmania major
by: Yaghoobi-Ershadi MR, et al.
Published: (2007-09-01) -
Colonization and Biology of Phlebotomus papatasi, the Main Vector of Cutaneous Leishmaniasis due to Leshmania major
by: Yaghoobi-Ershadi MR, et al.
Published: (2007-09-01) -
The use of different concentrations of leishmanial antigen in skin testing to evaluate delayed hypersensitivity in american cutaneous leishmaniasis
by: César A. Cuba Cuba, et al.
Published: (1985-12-01) -
The use of different concentrations of leishmanial antigen in skin testing to evaluate delayed hypersensitivity in american cutaneous leishmaniasis
by: César A. Cuba Cuba, et al.
Published: (1985-12-01)